Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

World Hemophilia Day 2016

Mother and father playing with babyRead and share the stories of people with hemophilia to raise awareness.

World Hemophilia Day is observed on April 17th every year. All around the world individuals and groups work together to ensure better diagnosis and access to care for the millions of men, women and children who have a bleeding disorder, yet remain without treatment. In the United States alone, there are an estimated 20,000 individuals living with hemophilia. Below, we share the stories of some individuals living with hemophilia.

Hemophilia is a hereditary (inherited) disease usually diagnosed soon after birth. People with hemophilia lack a protein (a clotting factor) necessary for blood to clot normally. This can lead to spontaneous bleeding, as well as bleeding following injuries or surgery.

"Matthew was born normally, with no complications. We knew he would have hemophilia and that was confirmed at birth, but he experienced no bleeds and required no treatment until he had an elective surgery at six months to correct a foot defect." – Matthew's Story

Couple sitting in car and using selfie stick

You can participate in World Hemophilia Day 2016 by sharing stories and information about hemophilia on social media using the hashtag #WorldHemoDay.

The best way to treat hemophilia is to replace the missing blood clotting factor so that the blood can clot properly. This is done by infusing (giving through a needle into a vein) commercially prepared clotting factor concentrates, a substance that helps people with hemophilia form blood clots to stop bleeding.

"During foot surgery Matthew had a device called a central line, placed in his vein to deliver his first doses of clotting factor. The plan was that we would begin routine preventative treatment, called prophylaxis, to reduce the number of bleeds that he might eventually have." – Matthew's Story

Up to 1 in 5 people with hemophilia develop an antibody (inhibitor) to the infused clotting factor used to treat bleeding episodes. The inhibitor prevents the clotting factor from working to stop bleeding. An inhibitor makes treatment for bleeding episodes much more difficult and expensive.

"Like many very young children with hemophilia, Caeleb started showing signs of his bleeding disorder with bruises from minor bumps. He was circumcised at 11 months and just would not stop bleeding. The doctor's diagnosed Caeleb with a high titer inhibitor, which is an antibody that does not allow the factor to work to stop bleeding. His older brother who also had hemophilia also had an inhibitor at the same age." – Caeleb's Story

It is possible to develop long-term joint problems caused by the bleeding.

"Other challenges of living with an inhibitor that we've faced include management of short- and long-term pain from repeat joint bleeds, dependence on and side effects from pain medications, inability to participate fully in sports and activities due to physical limitations, many school absences, and concerns over the costs of medications." – Thomas' Story
"He bleeds frequently. He now is confined to a wheelchair due to the joint damage from repeated bleeding in his knees. He has had several major surgeries to stop bleeding in his joints and to try to relieve his pain." – Matthew's Story

People with hemophilia can live normal lives.

"Matt graduated from high school with good grades, and he is now in college. He has a girlfriend, he drives a car, and he has a job. He has coped amazingly well. He is a very intelligent, funny, and talented young man." – Matthew's Story

CDC is continuously working to improve the health of people living with bleeding disorders. The Division of Blood Disorders engages in research and training, and supports programs to positively impact the lives of people with bleeding disorders like Community Counts. For more resources, please visit our website.

Top